These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4734005)

  • 1. Effect of single or repeated administration of chlorpromazine on the disappearance of mescaline in mouse.
    Shah NS; Gibson BR
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):321-4. PubMed ID: 4734005
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of chlorpromazine and haloperidol on the disposition of mescaline-14C in mice.
    Shah NS; Shah KR; Lawrence RS; Neely AE
    J Pharmacol Exp Ther; 1973 Aug; 186(2):297-304. PubMed ID: 4719782
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolongation of the disappearance of mescaline-14C by SKF 525-A.
    Shah NS; Gibson BR
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):779-82. PubMed ID: 4750115
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug interaction--effect of chlorpromazine on the disposition of 8- 14 C-mescaline in fetal and maternal brain and liver in pregnant mouse.
    Shah NS; Neely AE
    Biochem Pharmacol; 1973 Jun; 22(12):1535-8. PubMed ID: 4732531
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxidative metabolism of mescaline in the central nervous system. II. Oxidative deamination of mescaline and 2,3,4-trimethoxy-beta-phenylethylamine by different mouse brain area in vitro.
    Seiler N; Demisch L
    Biochem Pharmacol; 1971 Sep; 20(9):2485-93. PubMed ID: 5163157
    [No Abstract]   [Full Text] [Related]  

  • 6. Tissue levels of mescaline in mice: influence of chlorpromazine on repeated administration of mescaline.
    Shah NS; Green C
    Eur J Pharmacol; 1973 Dec; 24(3):334-40. PubMed ID: 4766694
    [No Abstract]   [Full Text] [Related]  

  • 7. Further studies on the chlorpromazine-induced prolongation of the disappearance of mescaline from mouse tissues.
    Shah NS; Gulati OD
    Toxicol Appl Pharmacol; 1975 Dec; 34(3):441-8. PubMed ID: 1209638
    [No Abstract]   [Full Text] [Related]  

  • 8. The uptake and distribution of 14-C-mescaline in different organs of developing rat.
    Shah NS; Shah KR; Lawrence RS; Neely AE
    Drug Metab Dispos; 1975; 3(2):74-9. PubMed ID: 236161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative metabolism of mescaline in the central nervous system. 3. Side chain degradation of mescaline and formation of 3,4,5-trimethoxy-benzoic acid in vivo.
    Seiler N; Demisch L
    Biochem Pharmacol; 1974 Jan; 23(2):259-71. PubMed ID: 4813343
    [No Abstract]   [Full Text] [Related]  

  • 10. Placental transfer and tissue distribution of mescaline- 14 C in the mouse.
    Shah NS; Neely AE; Shah KR; Lawrence RS
    J Pharmacol Exp Ther; 1973 Feb; 184(2):489-93. PubMed ID: 4688184
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxidative metabolism of mescaline in the central nervous system. IV. In vivo metabolism of mescaline and 2,3,4-trimethoxy-beta-phenylethylamine.
    Seiler N; Demisch L
    Biochem Pharmacol; 1974 Jan; 23(2):273-87. PubMed ID: 4813344
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of psychotropic drugs and beta-diethylaminoethyl-diphenylpropylacetate (SKF 525-A) on mescaline-induced behavior and on tissue levels of mescaline in mice.
    Shah NS
    Biochem Pharmacol; 1976 Mar; 25(5):591-7. PubMed ID: 8055
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mescaline induced bradycardia and its antagonistic modification by chlorpromazine, pentobarbital and scopolamine after injection into lateral cerebral ventricle of mouse].
    Lehr E; Werner G
    Arzneimittelforschung; 1970 Jul; 20(7):901-3. PubMed ID: 5536053
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative study on the metabolism of 3,4-dimethoxyphenylethylamine-C 14 and mescaline-C 14 by rabbit, mouse and rat brain homogenates.
    Shah NS
    Arch Int Pharmacodyn Ther; 1971 Oct; 193(2):357-61. PubMed ID: 5119220
    [No Abstract]   [Full Text] [Related]  

  • 15. [Molecular biological approach to psychiatric problems using studies with mescaline].
    Denber HC; Teller DN
    Psychiatr Pol; 1968; 2(2):113-20. PubMed ID: 5691330
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on mescaline XVIII: effect of phenothiazines, amphetamine and amobarbital sodium on uptake into brain and viscera.
    Denber HC; Teller DN
    Agressologie; 1968; 9(1):127-36. PubMed ID: 5681815
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oxidative degradation of mescaline in the central nervous system. I. Properties of the mescaline-degrading enzyme].
    Seiler N
    Hoppe Seylers Z Physiol Chem; 1965; 341(1):105-10. PubMed ID: 5896221
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of chlorpromazine on the disposition and excretion of amphetamine in the rat.
    Borella LE; Pinski J; Herr F
    Res Commun Chem Pathol Pharmacol; 1970 Sep; 1(5):667-76. PubMed ID: 5524269
    [No Abstract]   [Full Text] [Related]  

  • 19. [Autoradiography studies on the distribution of 3H-mescaline in mammals].
    Lehr E; Korr H; Seiler N; Werner G
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):268-9. PubMed ID: 4242414
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Modification of the effects of chlorpromazine on methamphetamine and barbiturates by repeated administration to mice.
    Furukawa T; Ushijima I; Hara T; Ono N
    Jpn J Pharmacol; 1974; 24(0):s:107. PubMed ID: 4545667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.